Medically Reviewed by Dr. Joel Cherdack, Founder — Houston Regenerative Medicine
Quick Summary
- There are four main types of stem cells used in regenerative medicine: adipose (fat-derived), bone marrow, umbilical cord, and amniotic — and they are not interchangeable.
- Your own cells (autologous) carry zero rejection risk; donor cells (“off-the-shelf”) carry FDA compliance concerns you need to understand before choosing a clinic.
- Combining adipose and bone marrow stem cells with PRP — the foundation of our acCELLerate™ Therapy — produces faster, more robust healing than any single source alone.
You’ve been told you need a knee replacement. Or your shoulder has been grinding for two years. Or you’ve watched three different clinics promise “stem cell therapy” without ever explaining what that actually means.
Here’s the truth: not all stem cells are the same. The type of cell used, where it comes from, and how it’s applied make an enormous difference in your results. And right now, most clinics aren’t telling you that.
This guide will change that. Let’s break down every major stem cell type used in modern regenerative medicine — what they are, what they’re best for, and the one question you should ask any clinic before you book a consultation.
The 4 Main Types of Stem Cells Used in Treatment
Think of stem cells like construction crews. When your tissue is damaged, your body sends out a distress signal — but sometimes the local crew is too small or too worn down to finish the job. Stem cell therapy floods the site with reinforcements.
But here’s what matters: not every construction crew has the same tools. Here’s a breakdown of the four types you’ll encounter.
1. Adipose-Derived Stem Cells (From Your Own Body Fat)
This is one of the most widely used sources in clinical regenerative medicine — and for good reason.
Adipose tissue (the fat just beneath your skin, typically harvested from the abdomen or flank) is remarkably rich in mesenchymal stem cells (MSCs) — the type most effective for repairing joints, tendons, and soft tissue. A single harvest can yield significantly more stem cells than bone marrow, making it a high-volume, minimally invasive option.
Because these are your own cells, there’s no risk of rejection. The procedure is done in-clinic, typically under local anesthesia, and most patients walk out the same day.
Best for: Knee osteoarthritis (Grade 1–3), shoulder injuries, hip degeneration, soft tissue repair.
Downtime: Minimal. Most patients resume light activity within 24–48 hours.
2. Bone Marrow-Derived Stem Cells (From Your Own Hip)
Bone marrow has been the gold standard of stem cell research for decades. The cells are harvested from the iliac crest (the back of your hip) using a specialized needle — a process that sounds intimidating but is routinely performed in-office with local anesthesia.
Bone marrow stem cells are particularly powerful for orthopedic and cartilage repair. They carry strong osteogenic (bone-forming) and chondrogenic (cartilage-forming) potential, making them especially valuable for patients with significant joint degeneration.
The tradeoff? Bone marrow yields fewer stem cells per harvest compared to adipose tissue. That’s exactly why combining both sources — the volume of adipose with the orthopedic potency of bone marrow — produces superior outcomes. It’s the foundation of our proprietary acCELLerate™ Therapy approach.
Best for: Advanced joint degeneration, cartilage repair, degenerative disc disease.
Downtime: Mild soreness at the harvest site for 2–5 days; most patients are mobile immediately.
3. Umbilical Cord Stem Cells (Donor-Derived)
This is where the marketing gets murky — and where you need to pay close attention.
Umbilical cord stem cells are harvested from donated cord tissue after healthy births (with full consent). They’re sometimes called “off-the-shelf” cells because they’re pre-processed and stored, ready to inject without a same-day harvest from your body.
The appeal is obvious: no extraction procedure, quick administration, and umbilical cells are biologically “young” with high proliferative potential.
The critical caveat: As of 2025, the FDA has issued specific warnings regarding many umbilical cord and amniotic products marketed for joint injections. Many of these products do not meet the FDA’s criteria for minimally manipulated tissue and are not approved for orthopedic use. Some contain few to no live cells by the time they’re administered.
This doesn’t mean all donor-cell therapies are fraudulent — but it does mean you must ask your clinic directly whether their specific product is compliant with FDA 21 CFR Part 1271 guidelines.
At Houston Regenerative Medicine, we prioritize using your own live cells precisely because it eliminates this regulatory ambiguity entirely.
Best for: Certain systemic or inflammatory conditions (in compliant clinical settings).
Downtime: Minimal procedurally, but efficacy is highly dependent on product quality and compliance.
4. Amniotic Stem Cells (Donor-Derived)
Similar to umbilical cord products, amniotic tissue is derived from the amniotic sac donated after birth. It contains growth factors, cytokines, and hyaluronic acid — components that can reduce inflammation and support tissue repair.
Again, the same FDA compliance questions apply. Many amniotic “stem cell” products on the market are actually acellular — meaning they contain growth factors but no live stem cells at all. They can still have therapeutic value for inflammation, but calling them “stem cell therapy” is a stretch.
If a clinic is offering amniotic injections at a dramatically lower price point than autologous (your own cells) procedures, it’s worth asking what exactly is in the syringe.
Best for: Mild inflammation management, soft tissue support, adjunct therapy.
Downtime: Minimal.
Side-by-Side Comparison: Which Stem Cell Type Is Right for You?
| Cell Type | Source | Live Cells? | Best Application | Avg. Downtime | FDA Compliance Risk |
| Adipose | Your body fat | Yes | Joint pain, soft tissue, hair loss | 24–48 hrs | Low (autologous) |
| Bone Marrow | Your hip (iliac crest) | Yes | Cartilage, bone, disc degeneration | 2–5 days | Low (autologous) |
| Umbilical Cord | Donor (post-birth) | Varies | Systemic/inflammatory (if compliant) | Minimal | High — verify product |
| Amniotic | Donor (post-birth) | Often acellular | Inflammation, adjunct support | Minimal | High — verify product |
Why Combining Sources Produces Better Results
Here’s something most clinic websites won’t tell you: no single cell source does everything well.
Adipose tissue gives you volume. Bone marrow gives you orthopedic potency. And PRP (Platelet-Rich Plasma) — drawn from your own blood — acts as the biological “activator” that signals those stem cells to get to work faster.
Think of it this way: stem cells are the construction crew, and PRP is the foreman who tells them exactly where to go and what to build.
Our acCELLerate™ Therapy combines all three in a single, same-day procedure performed right in our Houston lab. This combined approach is intended to draw on both cell populations in a single, same-day procedure.
“Walking and stairs have been so incredibly painful. After my treatment, I had no downtime, and I’m feeling so much better.” — Houston Regenerative Medicine Patient
The Autologous Advantage: Why Your Own Cells Win
“Autologous” simply means from your own body. And when it comes to regenerative medicine, it’s the gold standard.
When we use your own adipose and bone marrow cells, we eliminate three major risks:
- Immune rejection — Your body can’t reject what it already owns.
- Disease transmission — No donor-to-patient transfer risk.
- Regulatory ambiguity — Your own cells, minimally processed, are clearly within FDA guidelines.
This is why we approach each patient as a unique individual. We’re not pulling a product off a shelf — we’re harvesting your biology, concentrating it, and returning it to the exact site that needs repair. That’s not a marketing line. That’s the science of why autologous therapy works.
What Conditions Respond Best to Each Cell Type?
If you’re evaluating stem cell therapy for knee osteoarthritis, bone marrow and adipose cells — ideally combined — are your strongest options. The research on MSCs for cartilage repair is the most robust in the field.
For degenerative disc disease, bone marrow-derived cells have shown the most promise in peer-reviewed literature, particularly when combined with PRP to enhance the disc’s hydration and structural integrity.
For hair restoration, adipose-derived cells and PRP work synergistically to revive dormant hair follicles and improve blood circulation to the scalp — a completely different mechanism than joint repair, but using the same biological toolkit.
For rotator cuff tears and shoulder injuries, adipose cells are typically preferred due to their anti-inflammatory properties and the high volume of cells available per harvest.
Unsure which approach fits your specific situation? We offer a free consultation to map your diagnosis to the right protocol — no commitment required.
A Note on FDA Compliance in 2025
This is the section most clinics skip. We won’t.
The FDA regulates stem cell products under 21 CFR Part 1271. In simple terms: if a cell product is “more than minimally manipulated” or used for purposes other than its original function, it requires full FDA approval as a drug or biologic — a process that most off-the-shelf clinic products have not completed.
In 2025, the FDA has continued enforcement actions against clinics marketing unapproved umbilical cord and amniotic “stem cell” products for conditions like osteoarthritis, neuropathy, and macular degeneration. These aren’t fringe cases — they’ve affected well-known national chains.
The safest path? Autologous therapy using your own cells, performed by a physician with documented expertise in orthobiologic applications. That’s the standard we hold ourselves to at Houston Regenerative Medicine.
Conclusion & Next Steps
Here’s the bottom line: stem cell therapy isn’t one thing — it’s a category. And the difference between a life-changing outcome and a disappointing one often comes down to which cells are used, from what source, and how they’re combined.
If you’re evaluating your options for joint pain, a sports injury, or age-related degeneration, don’t settle for a clinic that won’t answer the question: “Where exactly do these cells come from?”
We will always answer that question. Because at Houston Regenerative Medicine, natural healing without surgery isn’t a tagline — it’s the entire philosophy behind every treatment we offer.
Ready to find out which stem cell protocol is right for your specific condition? Let’s talk. Schedule Your Free Consultation Today →
Frequently Asked Questions
What is the most effective type of stem cell therapy for knee osteoarthritis?
For knee osteoarthritis (Grade 1–3), a combination of adipose-derived and bone marrow-derived stem cells — paired with PRP — produces the most robust outcomes. Adipose cells provide high volume and anti-inflammatory properties, while bone marrow cells contribute cartilage-regenerating potential. Using both sources together, as in our acCELLerate™ Therapy, typically yields faster improvement and more durable results than any single source alone.
Are umbilical cord stem cells safe and FDA-approved for joint pain?
This depends entirely on the specific product and clinic. As of 2025, the FDA has issued warnings against many off-the-shelf umbilical cord products marketed for joint injections that have not received proper approval. Some contain few or no live cells. Always ask your provider for documentation of FDA compliance. Autologous therapy — using your own cells — carries no such regulatory risk and remains the gold standard for orthopedic applications.
Why do some clinics use your own cells while others use donor cells?
Autologous clinics (using your own adipose or bone marrow cells) prioritize safety, zero rejection risk, and clear FDA compliance. Donor-cell clinics often use off-the-shelf products for convenience and lower procedural cost. The tradeoff is that donor products vary widely in quality, live cell content, and regulatory status. For most patients seeking durable joint repair, autologous therapy from a qualified physician remains the more evidence-backed and transparent choice.
What is Stem Cell Therapy? Understanding the Basics
